Abcellera Biologics Inc Free Cash Flow Generation Index
Abcellera Biologics Inc free cash flow generation index. Abcellera Biologics Inc (ABCL) has a Free Cash Flow Generation Index of -0.38x as of June 2023. Free cash flow of $-7.53 Million represents 0% of operating cash flow ($19.82 Million). Check ABCL cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Abcellera Biologics Inc (2018–2022)
Free cash flow generation index of Abcellera Biologics Inc from 2018 to 2022. Historical FCF Generation Index trend for Abcellera Biologics Inc across 5 annual periods. Explore ABCL capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Abcellera Biologics Inc Free Cash Flow Generation Index by Year (2018–2022)
Abcellera Biologics Inc free cash flow generation index by year from 2018 to 2022. Year-by-year Free Cash Flow Generation Index for Abcellera Biologics Inc. For the full cash flow conversion analysis, see how efficiently does Abcellera Biologics Inc generate cash.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.74x | $204.70 Million | $277.36 Million | $72.66 Million | ▼ -3.0% |
| 2021 | 0.76x | $186.13 Million | $244.58 Million | $58.45 Million | ▲ +115.4% |
| 2020 | 0.35x | $8.02 Million | $22.69 Million | $14.67 Million | ▲ +173.1% |
| 2019 | -0.48x | $-1.30 Million | $2.69 Million | $4.00 Million | ▲ +1.0% |
| 2018 | -0.49x | $-1.74 Million | $3.56 Million | $5.31 Million | — |